The recent instability in global chains have highlighted the necessity of securing critical medications like Ivermectin. Dependence on overseas vendors exposes regions to considerable vulnerabilities, including delivery delays, expense fluctuations, and even political threats. Transitioning towards domestic sourcing of Ivermectin offers a multitude